Trials / Completed
CompletedNCT01197794
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
A Double-blind, Placebo-controlled, Randomised, Parallel-group, Phase II, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of 4 Twice Daily Doses and 2 Once Daily Doses of AZD1981 Given as Tablets During 12 Weeks in Asthmatic Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1,144 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will assess the efficacy, safety and tolerability of AZD1981 compared to non-active compound in asthmatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD1981 | AZD1981 twice daily |
| DRUG | AZD1981 | AZD1981 once daily |
| DRUG | Placebo | Placebo to match AZD1981 |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2010-09-09
- Last updated
- 2013-11-06
- Results posted
- 2013-09-10
Locations
105 sites across 10 countries: United States, Argentina, Brazil, Japan, Mexico, Romania, Russia, Slovakia, South Africa, Ukraine
Source: ClinicalTrials.gov record NCT01197794. Inclusion in this directory is not an endorsement.